298 related articles for article (PubMed ID: 9046118)
1. Cardiovascular complications in end-stage renal disease and hemodialysis patients.
Kes P; Drusko D; Rupcić V
Acta Med Croatica; 1996; 50(4-5):199-208. PubMed ID: 9046118
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmias in hemodialysis patients.
Voroneanu L; Covic A
J Nephrol; 2009; 22(6):716-25. PubMed ID: 19967650
[TBL] [Abstract][Full Text] [Related]
7. [Conditions and consequences of cardiac alterations in patients with end-stage renal disease on maintenance hemodialysis].
Zabicka H
Postepy Hig Med Dosw; 1996; 50(3):277-91. PubMed ID: 8927587
[TBL] [Abstract][Full Text] [Related]
8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
10. Cardiac disease in patients with end-stage renal disease.
Staffeld CG; Pastan SO
Cardiol Clin; 1995 May; 13(2):209-23. PubMed ID: 7614511
[TBL] [Abstract][Full Text] [Related]
11. Sleep apnea and daytime sleepiness in end-stage renal disease.
Hanly P
Semin Dial; 2004; 17(2):109-14. PubMed ID: 15043611
[TBL] [Abstract][Full Text] [Related]
12. [Chronic inflammation and cardiovascular risk in hemodialysis].
Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
[TBL] [Abstract][Full Text] [Related]
14. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
Kessler M; Zannad F; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P;
Nephrol Dial Transplant; 2007 Dec; 22(12):3573-9. PubMed ID: 17611249
[TBL] [Abstract][Full Text] [Related]
15. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors and diseases strongly predict hemodialysis treatment outcome in maintenance hemodialysis patients.
Racki S; Zaputović L; Vujicić B; Mavrić Z; Grzetić M; Ravlić-Gulan J
Croat Med J; 2005 Dec; 46(6):936-41. PubMed ID: 16342347
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
Cases A; Vera M; López Gómez JM
Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
[TBL] [Abstract][Full Text] [Related]
18. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
Kes P
Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of cardiovascular disease in chronic renal disease.
Foley RN; Parfrey PS; Sarnak MJ
J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcome in asymptomatic hemodialysis patients submitted to aggressive medical therapy: results of a four-year follow-up.
Summaria F; Manca Di Villahermosa S; Tedesco M; Lonzi M; Colarieti G; Chamoun MG; Taccone Gallucci M
Minerva Cardioangiol; 2011 Apr; 59(2):121-6. PubMed ID: 21242949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
